U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07210034) titled 'What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients With Myelodysplastic Syndromes' on Sept. 29.
Brief Summary: to investigate prognostic significance of many factors in MDS including HALP score ( haemoglobin level, albumin level, lymphocyte, platelets), monocytopenia, hyperfibrinogenemia and AST/ALT ratio in patients with MDS at Assiut University Hospital.
And to study overall survival and leukemia free survival rates in MDS patients.
Study Start Date: Jan. 01, 2026
Study Type: OBSERVATIONAL
Condition:
Myelo Dysplastic Syndrome
Recruitment Status: NOT_YET_RECRUITING
Spo...